Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Kaasinen

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Acta Neurologica Scandinavica|November 11, 2015
Pharmacotherapy and generic health-related quality of life in Parkinson's diseaseJ T Järvelä, V Kaasinen
Acta Neurologica Scandinavica|June 7, 2016
No relevant midbrain atrophy in Parkinson's diseaseE Mäkinen, J Joutsa, J Isotalo, et al.
European Journal of Neurology|August 24, 2017
Ventral striatal dopaminergic defect is associated with hallucinations in Parkinson's diseaseE Jaakkola, J Joutsa, E Mäkinen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 21, 2004
Hippocampal and prefrontal atrophy in patients with early non-demented Parkinson's disease is related to cognitive impairmentA Brück, T Kurki, V Kaasinen, et al.
The American Journal of Psychiatry|February 7, 2001
Sex differences in extrastriatal dopamine d(2)-like receptors in the human brainV Kaasinen, K Någren, J Hietala, et al.
Journal of Neurology|October 14, 2005
Corticostriatal covariance patterns of 6-[18F]fluoro-L-dopa and [18F]fluorodeoxyglucose PET in Parkinson's diseaseV Kaasinen, R P Maguire, H-P Hundemer, et al.
Neuroimage|January 4, 2005
Mapping brain structure and personality in late adulthoodV Kaasinen, R P Maguire, T Kurki, et al.
Translational Psychiatry|January 7, 2015
Dopaminergic function and intertemporal choiceJ Joutsa, V Voon, J Johansson, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 28, 2003
Extrastriatal dopamine D(2) receptors in Parkinson's disease: a longitudinal studyV Kaasinen, S Aalto, K NAgren, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 2000
Upregulation of putaminal dopamine D2 receptors in early Parkinson's disease: a comparative PET study with [11C] raclopride and [11C]N-methylspiperoneV Kaasinen, H M Ruottinen, K Någren, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Acta Neurologica Scandinavica|November 11, 2015
Pharmacotherapy and generic health-related quality of life in Parkinson's diseaseJ T Järvelä, V Kaasinen
Acta Neurologica Scandinavica|June 7, 2016
No relevant midbrain atrophy in Parkinson's diseaseE Mäkinen, J Joutsa, J Isotalo, et al.
European Journal of Neurology|August 24, 2017
Ventral striatal dopaminergic defect is associated with hallucinations in Parkinson's diseaseE Jaakkola, J Joutsa, E Mäkinen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 21, 2004
Hippocampal and prefrontal atrophy in patients with early non-demented Parkinson's disease is related to cognitive impairmentA Brück, T Kurki, V Kaasinen, et al.
The American Journal of Psychiatry|February 7, 2001
Sex differences in extrastriatal dopamine d(2)-like receptors in the human brainV Kaasinen, K Någren, J Hietala, et al.
Journal of Neurology|October 14, 2005
Corticostriatal covariance patterns of 6-[18F]fluoro-L-dopa and [18F]fluorodeoxyglucose PET in Parkinson's diseaseV Kaasinen, R P Maguire, H-P Hundemer, et al.
Neuroimage|January 4, 2005
Mapping brain structure and personality in late adulthoodV Kaasinen, R P Maguire, T Kurki, et al.
Translational Psychiatry|January 7, 2015
Dopaminergic function and intertemporal choiceJ Joutsa, V Voon, J Johansson, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 28, 2003
Extrastriatal dopamine D(2) receptors in Parkinson's disease: a longitudinal studyV Kaasinen, S Aalto, K NAgren, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 2000
Upregulation of putaminal dopamine D2 receptors in early Parkinson's disease: a comparative PET study with [11C] raclopride and [11C]N-methylspiperoneV Kaasinen, H M Ruottinen, K Någren, et al.
Pageof 2